An observational study in Embolic Stroke of Undetermined Source, sponsored by Population Health Research Institute. Completed at 44 sites in 13 countries. Open to participants aged 21 Years to 50 Years. Per ClinicalTrials.gov, last updated 2021-02-04.
Sponsored by Population Health Research Institute · Observational
This study seeks to determine the clinical characteristics of young ESUS patients using diagnostic criteria of the Cryptogenic Stroke / ESUS International Working Group, and to determine the rates of stroke recurrence, death, and hospital readmission in a contemporary cohort of young ESUS patients during follow-up of up to 18 months.
Patients presenting to hospital-based stroke unit with an ESUS Stroke
Embolic stroke of undetermined source (ESUS) within 60 days, defined as:
Exclusion Criteria:
Recurrent ischemic stroke and/or death in a well-defined Young ESUS cohort
Time frame: Approximately 18 Months
Recurrent ischemic stroke in a well-defined Young ESUS cohort
Time frame: Approximately 18 Months
Prevalence of Patent Foramen Ovale in a well-defined Young ESUS cohort
Time frame: Baseline
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Population Health Research Institute